You are here
J&J invests in experimental drugs as competitive threats loom
JOHNSON & JOHNSON is investing in a collection of experimental drugs with blockbuster potential, treating widespread illnesses such as blood cancer and Alzheimer's disease, to help rise above looming competitive threats to its pharmaceutical business.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org